Global Immuno-Oncology Assays Market (2021 to 2026) - Growing Significance of Companion Diagnostics Presents Opportunities
May 14, 2021 05:23 ET
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications...
Cytovia Therapeutics Expands Leadership Team
May 13, 2021 09:48 ET
|
Cytovia Therapeutics
Jason Aryeh elected to Board of DirectorsElizabeth Schwarzbach, PhD and Boris Reznik, PhD join Strategic Advisory BoardElysa Mantel appointed as Vice President, General Counsel and Corporate Secretary...
Acepodia Appoints Thorsten Graef, M.D., Ph.D., as Chief Medical Officer and Michael Brock as Chief Strategy Officer
May 11, 2021 08:00 ET
|
Acepodia USA
SAN MATEO, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Acepodia, a biotechnology company developing next generation solid tumor and hematologic cancer cell therapies, today announced the appointments...
Immatics präsentiert präklinische Proof-of-Concept-Daten für das bispezifische TCR-Programm IMA402 gegen PRAME
May 11, 2021 07:00 ET
|
Immatics N.V.
Zweites bispezifisches T-Zell-Rezeptor (TCR)-Programm IMA402 zeigte Anti-Tumorwirkung im In-vivo-Mausmodell und führte zu vollständigen Remissionen etablierter TumoreIMA402 ist gegen ein Peptid...
Immatics Presents Preclinical Proof-of-Concept Data for TCR Bispecifics Program IMA402 Targeting PRAME
May 11, 2021 07:00 ET
|
https://immatics.com/
Immatics’ second TCR Bispecifics program IMA402 demonstrates tumor cell killing in vitro and complete regressions of established tumors in an in vivo tumor modelIMA402 targets an Immatics-validated...
Global CAR-T Therapy Pipeline Market Analysis Report 2021: Focus on CD19, CD22, Others - Long-term Forecast to 2025 & 2030
May 11, 2021 05:33 ET
|
Research and Markets
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
CatalYm Appoints Industry Leader Dr. Phil L’Huillier as Chief Executive Officer
May 04, 2021 05:00 ET
|
CatalYm GmbH
MUNICH, Germany, May 04, 2021 (GLOBE NEWSWIRE) -- CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, today announced the appointment of Dr. Phil L’Huillier as Chief...
Global Allergy Treatment Market Report 2021: Market is Expected to Reach $35.81 Billion by 2028 - Development and Approvals of Innovative Medicines such as Biologics Gaining Momentum
April 29, 2021 07:33 ET
|
Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Allergy Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food...
Stanley R. Frankel, MD, FACP joins Cytovia Therapeutics as Chief Medical Officer
April 28, 2021 13:16 ET
|
Cytovia Therapeutics
CAMBRIDGE, Mass. and AVENTURA, Fla., April 28, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited Chimeric Antigen...
Provectus Biopharmaceuticals Announces Acceptance of PV-10® Immunotherapy Abstracts at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
April 28, 2021 12:35 ET
|
Provectus Biopharmaceuticals Inc.
— Intralesional (aka intratumoral) PV-10 administration for treatment of hepatic metastatic neuroendocrine tumors (NCT02693067) — Systemic administration of PV-10 for treatment of solid tumor...